Follow the 보로노이 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 보로노이 has published 59 reports. Market capitalisation: €2,080.7bn. The latest transaction was filed on 22 June 2026 (Other). Among the most active insiders: 김현태. The full history is free.
59
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 보로노이 Buy (bullish), based on 1 analysts. Average price target: ₩450,000.
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,633 of 29,062 companies
40.2
score / 100
Value
29
Quality
52
FCF yld-2.4%
Earn yld-1.4%
EV/EBITDA·
ROE-70%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Boronois opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones innovadoras en el campo médico.